Retatrutide demonstrated substantial dose-dependent improvements in waist circumference and crucial cardiovascular risk factors, including non-HDL-C, triglycerides, systolic blood pressure, and ...

CHICAGO — CagriSema, a new weekly injection from Novo Nordisk combining the amylin analogue cagrilintide with the GLP-1 receptor agonist semaglutide, significantly reduced weight and improved ...

Experimental drug retatrutide cut weight by nearly 30% in Phase 3 trials, outperforming approved therapies, Eli Lilly says.

An 8-month low-calorie diet plus behavioral support helped older adults with overweight or obesity and persistent atrial ...

UK: Researchers have found in a new study that among older overweight patients with persistent atrial fibrillation (AF), a ...